Stock listing
Stuttgart:0ME Twist Bioscience Corporation Aktie
German listing (Stuttgart) of Twist Bioscience Corporation · home listing NASDAQ:TWST
Follow Twist Bioscience Corporation into a list and get an email when it puts out news.
Share price · SWB:0ME
€93.62 EUR -18.58 (-16.6%)
Close on Nov 20, 2026
- Day range
- €92.16 – €98.78 EURNov 20, 2026
- Volume
- 284 sharesNov 20, 2026
- Market cap
- €2.67B EURAt the close on Nov 20, 2026 · price × 28.55M shares outstanding
- 52-week range
- €22.46 – €188.10 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €16,708 EURMedian day 20 shares · 18 days with no trades · last 3 months, Aug 20, 2026 – Nov 12, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TWST · Home | $103.32 USD | -13.03 (-11.2%) | 3,378,941 | $108.39 | $108.50 | $101.00 | $116.35 | Close on Nov 20, 2026 |
| Frankfurt:0ME | €108.25 EUR | +6.00 (+5.9%) | — | €103.55 | €108.25 | €103.50 | €102.25 | Close on Nov 19, 2026 |
| Stuttgart:0ME | €93.62 EUR | -18.58 (-16.6%) | 284 | €97.00 | €98.78 | €92.16 | €112.20 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 12, 2026 · SWB:0ME · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €103.05 | -26.70 | -20.6% | €97.84 | €103.25 | €97.60 | 0 | |
| €129.75 | +11.10 | +9.4% | €124.00 | €129.75 | €124.00 | 103 | |
| €118.65 | +7.40 | +6.7% | €122.35 | €122.35 | €117.05 | 768 | |
| €111.25 | +4.20 | +3.9% | €107.90 | €111.25 | €107.00 | 0 | |
| €107.05 | +0.15 | +0.1% | €105.95 | €110.95 | €105.95 | 1,140 | |
| €106.90 | -19.75 | -15.6% | €125.20 | €125.20 | €106.90 | 200 | |
| €126.65 | +1.90 | +1.5% | €123.85 | €127.95 | €119.30 | 0 | |
| €124.75 | -10.75 | -7.9% | €118.95 | €125.25 | €118.55 | 0 | |
| €135.50 | -9.90 | -6.8% | €140.00 | €140.20 | €135.50 | 0 | |
| €145.40 | -5.60 | -3.7% | €144.70 | €145.45 | €143.20 | 16 | |
| €151.00 | +0.90 | +0.6% | €152.80 | €156.30 | €150.40 | 20 | |
| €150.10 | +6.45 | +4.5% | €143.30 | €152.55 | €143.25 | 51 | |
| €143.65 | +19.45 | +15.7% | €135.10 | €145.15 | €135.10 | 109 | |
| €124.20 | +0.05 | 0.0% | €123.80 | €124.55 | €122.50 | 0 | |
| €124.15 | 0.00 | 0.0% | €119.50 | €124.15 | €117.95 | 8 | |
| €124.15 | -8.95 | -6.7% | €126.80 | €129.35 | €124.15 | 8 | |
| €133.10 | +6.40 | +5.1% | €126.60 | €136.45 | €126.40 | 116 | |
| €126.70 | +1.90 | +1.5% | €123.25 | €131.75 | €121.35 | 14 | |
| €124.80 | -3.10 | -2.4% | €122.00 | €125.80 | €118.40 | 184 | |
| €127.90 | -0.70 | -0.5% | €129.40 | €129.40 | €127.10 | 0 | |
| €128.60 | -4.40 | -3.3% | €130.20 | €130.70 | €119.95 | 656 | |
| €133.00 | -1.45 | -1.1% | €133.95 | €134.70 | €130.25 | 2 | |
| €134.45 | -7.65 | -5.4% | €130.15 | €137.10 | €130.15 | 2 | |
| €142.10 | +3.65 | +2.6% | €144.50 | €144.50 | €140.90 | 16 | |
| €138.45 | +4.25 | +3.2% | €140.90 | €140.90 | €135.55 | 140 | |
| €134.20 | -4.20 | -3.0% | €137.15 | €137.15 | €131.85 | 8 | |
| €138.40 | -9.20 | -6.2% | €147.15 | €148.55 | €138.20 | 152 | |
| €147.60 | -35.95 | -19.6% | €182.60 | €188.10 | €147.60 | 282 | |
| €183.55 | +16.05 | +9.6% | €173.05 | €184.40 | €166.55 | 67 | |
| €167.50 | +0.50 | +0.3% | €165.90 | €170.75 | €163.20 | 34 | |
| €167.00 | -4.35 | -2.5% | €171.35 | €177.20 | €167.00 | 26 | |
| €171.35 | +7.80 | +4.8% | €165.10 | €172.65 | €163.70 | 980 | |
| €163.55 | +5.95 | +3.8% | €156.00 | €165.20 | €156.00 | 90 | |
| €157.60 | -2.95 | -1.8% | €161.50 | €163.00 | €156.25 | 188 | |
| €160.55 | -0.45 | -0.3% | €163.50 | €167.50 | €156.45 | 362 | |
| €161.00 | +21.55 | +15.5% | €140.35 | €162.00 | €135.95 | 134 | |
| €139.45 | -6.80 | -4.6% | €144.05 | €145.40 | €138.80 | 82 | |
| €146.25 | +1.95 | +1.4% | €143.15 | €148.05 | €143.15 | 440 | |
| €144.30 | -0.45 | -0.3% | €144.90 | €150.10 | €139.70 | 14 | |
| €144.75 | +8.95 | +6.6% | €134.90 | €144.75 | €134.05 | 94 | |
| €135.80 | +11.65 | +9.4% | €124.10 | €138.80 | €124.05 | 10 | |
| €124.15 | +4.90 | +4.1% | €118.60 | €125.85 | €118.40 | 0 | |
| €119.25 | +2.30 | +2.0% | €115.25 | €119.35 | €114.85 | 0 | |
| €116.95 | +7.55 | +6.9% | €108.85 | €117.70 | €106.50 | 90 | |
| €109.40 | +3.25 | +3.1% | €109.00 | €111.05 | €108.10 | 0 | |
| €106.15 | -2.10 | -1.9% | €107.20 | €107.35 | €106.15 | 60 | |
| €108.25 | -1.50 | -1.4% | €109.00 | €109.95 | €105.55 | 0 | |
| €109.75 | +3.65 | +3.4% | €107.00 | €110.10 | €105.10 | 0 | |
| €106.10 | -1.10 | -1.0% | €107.20 | €107.20 | €104.85 | 156 | |
| €107.20 | -3.35 | -3.0% | €109.60 | €111.75 | €106.40 | 10 | |
| €110.55 | -2.35 | -2.1% | €111.90 | €113.45 | €110.00 | 0 | |
| €112.90 | -0.30 | -0.3% | €113.05 | €113.10 | €110.20 | 0 | |
| €113.20 | -5.75 | -4.8% | €118.65 | €119.00 | €113.20 | 0 | |
| €118.95 | -3.25 | -2.7% | €120.90 | €123.10 | €117.00 | 305 | |
| €122.20 | -8.90 | -6.8% | €131.05 | €133.40 | €122.20 | 17 | |
| €131.10 | +2.60 | +2.0% | €127.70 | €132.90 | €126.10 | 212 | |
| €128.50 | +6.40 | +5.2% | €131.60 | €131.65 | €126.80 | 120 | |
| €122.10 | +1.70 | +1.4% | €119.25 | €123.20 | €119.25 | 0 | |
| €120.40 | -3.90 | -3.1% | €122.50 | €123.85 | €118.70 | 0 | |
| €124.30 | +7.30 | +6.2% | €118.00 | €124.30 | €116.40 | 0 | |
| €117.00 | -4.30 | -3.5% | €123.00 | €123.00 | €117.00 | 60 |
- Ticker
- Stuttgart:0ME
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Nov 12, 2026
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
Latest earnings call · Nov 12, 2026
Twist Bioscience (NASDAQ:TWST) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Nov 12, 2026
Q4 2026 Earnings Presentation
Earnings · 26 slides
Latest news
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
Nov 12, 2026
Closed €103.05 (-20.6%) on Nov 12, 2026
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Nov 11, 2026
Closed €129.75 (+9.4%) on Nov 11, 2026
Twist Bioscience to Present at Upcoming Investor Conferences
Nov 9, 2026
Closed €111.25 (+3.9%) on Nov 9, 2026
Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
Nov 3, 2026
Closed €126.65 (+1.5%) on Nov 4, 2026
Twist Bioscience Launches MRD Express with Rapid Turnaround Time
Oct 29, 2026
Closed €151.00 (+0.6%) on Oct 29, 2026
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
Oct 28, 2026
Closed €150.10 (+4.5%) on Oct 28, 2026
Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026
Oct 26, 2026
Closed €124.20 (0.0%) on Oct 26, 2026
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
Sep 16, 2026
Closed €124.15 (+4.1%) on Sep 16, 2026
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(4)
Aug 5, 2026
Closed €91.60 (+5.3%) on Aug 5, 2026
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
Aug 4, 2026
Closed €91.60 (+5.3%) on Aug 5, 2026
Twist Bioscience Corporation on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 25 in the last 12 months · 249 in all · newest Nov 12, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 12, 2026
- Decks
- 16 decks · latest Nov 12, 2026
Where Twist Bioscience Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TWST · Home listing | NASDAQ | United States | USD |
| gettex:0ME | gettex | Germany | EUR |
| Tradegate:0ME | Tradegate | Germany | EUR |
| Milan:1TWST | Milan | Italy | EUR |
| BOATS:TWST | BOATS | United States | USD |
| LS Exchange:A2N7L2 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2N7L2 | Lang & Schwarz | Germany | EUR |
| Frankfurt:0ME | Frankfurt | Germany | EUR |
| Dusseldorf:0ME | Dusseldorf | Germany | EUR |
| Hamburg:0ME | Hamburg | Germany | EUR |
| Munich:0ME | Munich | Germany | EUR |
| Stuttgart:0ME · This page | Stuttgart | Germany | EUR |
| BMV:TWST | BMV | Mexico | MXN |
| Hanover:0ME | Hanover | Germany | EUR |
| Xetra:0ME | Xetra | Germany | EUR |
Valuation
EV/sales 14.1× against a median of 6.9×: 10th lowest of 11 Diagnostics & research services companies shown. Statements: Year to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $6.46B USD
- P/E
- Loss
- EV/sales
- 14.1×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 7.9×
- Gross margin
- 52.4%
- Operating margin
- −30.3%
- Net margin
- −28.3%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 2.77
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corporation · NASDAQ:TWST | US$7.04B | US$6.46B | n/a | 14.1× | n/a | 7.9× | −28.3% | 0.0× | 2.77 |
| Tempus AI, Inc. · NASDAQ:TEM | US$9.58B | US$8.99B | n/a | 6.0× | n/a | 19.1× | −12.5% | 0.0× | 2.51 |
| Bruker Corporation · NASDAQ:BRKR | US$8.62B | US$10.22B | n/a | 2.9× | 64.4× | 3.7× | −3.5% | 0.7× | 1.72 |
| Pharmaron Beijing Co., Ltd. Class A · SZSE:300759 | US$8.52B | US$8.23B | 32.1× | 3.4× | n/a | 3.4× | 11.1% | 0.1× | n/a |
| GenScript Biotech Corporation · HKEX:1548 | US$8.08B | US$7.50B | n/a | 7.8× | 22.8× | 2.1× | −55.5% | 0.1× | n/a |
| Bio-Rad Laboratories, Inc. · NYSE:BIO | US$7.84B | US$7.38B | 7.7× | 2.8× | 71.0× | 1.0× | 39.5% | 0.2× | 0.72 |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832 | US$7.51B | US$7.10B | 27.8× | 9.8× | n/a | 5.3× | 37.2% | 0.0× | n/a |
| Asymchem Laboratories (Tianjin) Co., Ltd. Class A · SZSE:002821 | US$6.83B | US$5.89B | 38.5× | 5.3× | n/a | 2.6× | 15.9% | 0.0× | n/a |
| Bachem Holding AG Class B · SIX:BANB | US$6.80B | US$6.99B | 38.4× | 8.4× | 29.7× | 4.0× | 21.4% | 0.1× | n/a |
| 10x Genomics, Inc. · NASDAQ:TXG | US$6.29B | US$5.79B | n/a | 9.4× | n/a | 7.5× | −10.8% | 0.1× | 2.34 |
| Anthem Biosciences Limited · NSE:ANTHEM | US$5.78B | US$5.71B | 87.3× | 25.9× | 62.5× | 16.3× | 30.0% | 0.0× | n/a |
| Median of the others | US$7.67B | US$7.24B | 35.3× | 6.9× | 62.5× | 3.9× | 13.5% | 0.1× | 2.03 |
Forecasts
7 strong buy · 2 buy · 4 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 128.82 USD · Analysts' mean
- EPS, year to Sep 2027
- -0.49 · 4 analysts
- Revenue, year to Sep 2027
- 556M · 12 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Emily Leproust | CEO and Co-Founder of Twist |
| Adam Laponis | Chief Financial Officer |
| Patrick Finn | President and Chief Operating Officer |
| Dennis Cho | Chief Legal Officer and Corporate Secretary |
| Angela Bitting | Senior Vice President, Corporate Affairs; Chief Corporate Responsibility Officer |
| Jimmy Jin | Senior Vice President of Product and Marketing |
| Mark Buck | Senior Vice President of Operations |
| Nicole Moreno | Senior Vice President of Sales and Support |
| Paula Green | Senior Vice President of Human Resources |
| Keith Crandell | Co-Founder and Managing Director |
| Mike Fero | Chief Information Officer |
| Siyuan Chen | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Nelson C. Chan | Chairman of the Board |
Events
Calls
| Call | When | Status |
|---|---|---|
| Twist Bioscience (NASDAQ:TWST) Q4 2026 Earnings Call | Thu, Nov 12, 2026 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q3 2026 Earnings Call | Mon, Aug 03, 2026 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q2 2026 Earnings Call | Mon, May 04, 2026 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q1 2026 Earnings Call | Mon, Feb 02, 2026 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q4 2025 Earnings Call | Fri, Nov 14, 2025 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q3 2025 Earnings Call | Mon, Aug 04, 2025 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q2 2025 Earnings Call | Mon, May 05, 2025 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q1 2025 Earnings Call | Mon, Feb 03, 2025 · 8:00 AM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q4 2024 Earnings Call | Mon, Nov 18, 2024 · 8:00 PM ET | Replay |
| Twist Bioscience (NASDAQ:TWST) Q3 2024 Earnings Call | Fri, Aug 02, 2024 · 8:00 AM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2026 | Nov 12, 2026 · Before open | −6.8% |
| Q3 2026 | Aug 3, 2026 · Before open | +10.4% |
| Q2 2026 | May 4, 2026 · Before open | −7.0% |
| Q1 2026 | Feb 2, 2026 · Before open | +14.0% |
| Q4 2025 | Nov 14, 2025 · Before open | −10.1% |
| Q3 2025 | Aug 4, 2025 · Before open | −10.3% |
| Q2 2025 | May 5, 2025 · Before open | −8.4% |
| Q1 2025 | Feb 3, 2025 · Before open | +0.7% |
| Q4 2024 | Nov 18, 2024 · Before open | +12.3% |
| Q3 2024 | Aug 2, 2024 · Before open | −19.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2024 | May 2, 2024 · After close | +28.7% |
| Q1 2024 | Feb 2, 2024 · Before open | +10.0% |
| Q4 2023 | Nov 17, 2023 · Before open | +25.9% |
| Q3 2023 | Aug 4, 2023 · Before open | +11.2% |
| Q2 2023 | May 5, 2023 · Before open | −0.4% |
| Q1 2023 | Feb 3, 2023 · Before open | −18.1% |
| Q4 2022 | Nov 18, 2022 · Before open | −2.3% |
| Q3 2022 | Aug 5, 2022 · Before open | +12.7% |
| Q2 2022 | May 5, 2022 · After close | +0.8% |
| Q1 2022 | Feb 4, 2022 · Before open | −2.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2026 Earnings Presentation | Earnings | 26 slides | Nov 12, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 29 slides | Aug 3, 2026 |
| William Blair 46th Annual Growth Stock Conference (May 2026) | Conference | 36 slides | May 2026 |
| Q2 2026 Earnings Presentation | Earnings | 25 slides | May 2026 |
| Q1 2026 Earnings Presentation | Earnings | 24 slides | Feb 2, 2026 |
| J.P. Morgan 2026 Healthcare Conference | Conference | 38 slides | January 2026 |
| Q4 2025 Earnings Presentation | Earnings | 20 slides | Nov 14, 2025 |
| Investor Presentation (September 2025) | Investor deck | 10 slides | September 2025 |
| Q3 2025 Earnings Presentation | Earnings | 21 slides | Aug 4, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 23 slides | May 5, 2025 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 FY2024 Earnings Presentation | Earnings | 17 slides | February 2024 |
| FY2023 Earnings Presentation | Earnings | 18 slides | November 2023 |
| Q3 FY2023 Earnings Presentation | Earnings | 17 slides | August 2023 |
| Technical Presentation (June 2022) | Technical | 24 slides | Jun 1, 2022 |
| 37th Annual JPM Healthcare Conference 2019 | Conference | 33 slides | Jan 7, 2019 |
| Investor Presentation (November 2018) | Investor deck | 36 slides | Nov 27, 2018 |
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Made bigger: US$300M · US$96 a share · Goldman Sachs & Co. LLC +3 Dealers: Goldman Sachs & Co. LLC (co-lead), William Blair (co-lead), Leerink Partners (co-lead), Guggenheim Securities (co-lead) Use of proceeds: Research and development, manufacturing capacity expansion, product offerings, working capital and general corporate purposes | Aug 5, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 459.4M | 376.6M | 313.0M | 245.1M | 203.6M | 132.3M | 90.1M | 54.4M | 25.4M | 10.8M |
| Cost of revenue | 218.6M | 185.6M | 179.6M | 155.4M | 119.3M | 80.6M | 61.4M | 47.4M | 32.2M | 24.0M |
| Gross profit | 240.8M | 191.0M | 133.3M | 89.7M | 84.2M | 51.7M | 28.7M | 6.96M | -6.76M | -13.3M |
| Research and development | 71.8M | 80.3M | 90.9M | 106.9M | 120.3M | 69.1M | 43.0M | 35.7M | 20.3M | 19.2M |
| Selling, general and administrative | 301.2M | 247.0M | 218.4M | 189.7M | 212.9M | 135.9M | 103.3M | 80.1M | 43.5M | 26.1M |
| Operating income | -139.5M | -136.3M | -220.8M | -217.2M | -234.8M | -152.7M | -140.1M | -108.8M | -70.6M | -58.5M |
| Depreciation and amortization | 26.5M | 24.9M | 31.4M | 29.3M | 16.5M | 9.75M | 6.68M | 6.11M | 5.73M | 5.02M |
| EBITDA | -113.0M | -111.4M | -189.4M | -187.8M | -218.3M | -143.0M | -133.4M | -102.7M | -64.8M | -53.5M |
| Interest expense | 29.0K | 5.00K | 80.0K | 367.0K | 787.0K | 1.29M | 1.31M | 905.0K | ||
| Income before tax | -129.8M | -77.0M | -208.2M | -203.5M | -228.3M | -154.0M | -139.5M | -107.4M | -71.0M | -59.0M |
| Income tax | 406.0K | 719.0K | 560.0K | 1.15M | -10.4M | -1.93M | 382.0K | 292.0K | 242.0K | 280.0K |
| Net income | -130.2M | -77.7M | -208.7M | -204.6M | -217.9M | -152.1M | -139.9M | -107.7M | -71.2M | -59.3M |
| Earnings per share, basic | -2.08 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 | -25.51 | -24.49 |
| Earnings per share, diluted | -2.08 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 | -25.51 | -24.49 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 534.0M | 183.0M | 226.3M | 286.5M | 378.7M | 465.8M | 93.7M | 46.7M | 80.8M | 31.2M |
| Short-term investments | 47.9M | 49.4M | 50.1M | 49.9M | 126.3M | 12.0M | 196.3M | 91.4M | 0 | 31.0M |
| Receivables | 70.2M | 57.0M | 34.9M | 44.1M | 40.3M | 28.5M | 26.4M | 12.1M | 5.42M | 2.35M |
| Inventory | 46.4M | 28.3M | 24.1M | 32.1M | 39.3M | 31.8M | 12.3M | 7.33M | 6.03M | 1.83M |
| Current assets | 737.2M | 333.0M | 346.8M | 424.3M | 596.5M | 546.5M | 334.9M | 160.1M | 95.7M | 67.9M |
| Property, plant and equipment | 122.3M | 102.3M | 102.5M | 131.8M | 139.4M | 44.1M | 25.5M | 20.8M | 12.3M | 14.8M |
| Goodwill | 82.2M | 82.2M | 85.8M | 85.8M | 85.8M | 22.4M | 1.14M | 1.14M | 1.14M | 1.14M |
| Total assets | 1.12B | 641.9M | 614.3M | 776.4M | 961.4M | 702.1M | 398.9M | 187.0M | 115.8M | 85.7M |
| Accounts payable | 24.9M | 11.1M | 1.63M | 14.1M | 20.1M | 14.9M | 4.83M | 9.76M | 7.53M | 2.85M |
| Current liabilities | 125.8M | 91.4M | 71.0M | 73.3M | 90.7M | 63.1M | 36.0M | 30.4M | 18.5M | 9.48M |
| Long-term debt | 1.40M | 4.40M | 7.22M | 9.15M | ||||||
| Total debt | 137.3M | 85.0M | 94.1M | 0 | 1.55M | 4.17M | 7.50M | 9.72M | 218.6M | |
| Total liabilities | 233.8M | 168.9M | 141.6M | 153.0M | 172.0M | 121.3M | 62.6M | 34.9M | 26.7M | 219.0M |
| Shareholders' equity | 888.0M | 473.0M | 472.7M | 623.4M | 789.4M | 580.8M | 336.3M | 152.1M | -201.4M | -133.4M |
| Shares outstanding | 67.8M | 60.6M | 58.9M | 57.6M | 56.5M | 49.5M | 45.1M | 32.9M | 3.21M | 45.2M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -41.4M | -47.6M | -64.1M | -142.5M | -124.4M | -112.2M | -142.3M | -87.9M | -66.2M | -51.3M |
| Capital spending | -47.6M | -28.0M | -5.08M | -27.8M | -101.9M | -27.1M | -9.87M | -14.8M | -3.69M | -6.59M |
| Free cash flow | -89.0M | -75.6M | -69.2M | -170.3M | -226.2M | -139.3M | -152.1M | -102.7M | -69.9M | -57.9M |
| Cash from investing | -53.1M | -24.8M | -3.07M | 50.6M | -232.9M | 156.2M | -114.7M | -104.8M | 27.3M | -9.99M |
| Cash from financing | 446.7M | 28.5M | 6.89M | 911.0K | 270.5M | 329.2M | 303.7M | 158.6M | 88.8M | 63.8M |
| Share buybacks | -16.0K | -3.98M | -4.41M | -7.75M | -10.8M | -2.42M | 161.1M | 91.2M | 65.8M | |
| Change in cash | 352.2M | -43.7M | -60.1M | -91.0M | -87.1M | 373.1M | 46.8M | -34.1M | 50.0M | 2.51M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Nov 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 10-K · Annual report | Nov 16, 2026 | Annual report | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 10, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Nov 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 3, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 23, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 9, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 7, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 5, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 24, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 21, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 21, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 17, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 8, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 8, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 8, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 25, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 24, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 19, 2026 | Current report | SEC |
| 424B7 · Prospectus | Aug 19, 2026 | Offer document | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 18, 2026 | Current report | SEC |
| 144 · Notice of proposed sale | Aug 18, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Aug 12, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 12, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 11, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 7, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 7, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 6, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Aug 5, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Aug 5, 2026 | Offer document | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 5, 2026 | Other filings | SEC |
| 424B5 · Prospectus | Aug 4, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 3, 2026 | Quarterly report | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 3, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 23, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 9, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 25, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 22, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 22, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 22, 2026 | Other filings | SEC |
| S-3ASR · Registration statement | Jun 18, 2026 | Offer document | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 1, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 29, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 29, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 28, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 28, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 26, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 26, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 26, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 12, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 8, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 7, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 4, 2026 | Quarterly report | SEC |
| 144 · Notice of proposed sale | May 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 4, 2026 | Other filings | SEC |
| 8-K · Current report | May 4, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
This page holds 200 of 1,004 filings. Open Filings
Cap table
Built by 6ix from Twist Bioscience Corporation’s releases · as of Nov 11, 2026
- Common shares
- 68,178,692
- Fully diluted
- 68,196,373
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 68,178,692 | Nov 11, 2026 |
| Options and RSUs | 17,681 |
Warrants and options
| Lot |
|---|
| RSUs · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 11, 2026 | 68,178,692 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Nelson C. Chan Other companies: GCT Semiconductor Holding, Inc. (Director · Since at least Mar 26, 2024); Deckers Outdoor Corporation (Director · Since at least Dec 16, 2014); Synaptics Incorporated (Director · Since at least Feb 20, 2007); Socket Mobile, Inc. (Director · Oct 3, 2016 – May 22, 2019 · Past); Adesto Technologies Corporation (Director · Oct 26, 2015 – Jun 29, 2020 · Past); Outerwall Inc (Director · Jul 5, 2011 – Sep 23, 2016 · Past); Affymetrix Inc (Director · Mar 8, 2010 – Mar 31, 2016 · Past); Silicon Laboratories, Inc. (Director · Sep 10, 2007 – Apr 23, 2009 · Past); Sandisk Corporation (EVP & GM, Consumer Hndst Bus · Feb 1, 2006 – Nov 14, 2006 · Past) | Director · Since at least May 20, 2019 |
| Keith Crandell Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); 908 Devices Inc. (Director · Since at least Dec 17, 2020); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Apr 3, 2023 · Past); Adesto Technologies Corporation (Director · Oct 26, 2015 – Jun 4, 2019 · Past); Celebrate Express Inc (Director · Oct 19, 2006 – Aug 29, 2008 · Past) | Co-Founder and Managing Director · Since at least Oct 30, 2018 |
| Bob Ragusa Other companies: Alamar Biosciences, Inc. (Director · Since at least Sep 1, 2026); GRAIL, Inc. (Chief Executive Officer, Director · Since at least Jun 3, 2024); Illumina, Inc. (SVP, Global Quality & Ops · Jan 1, 2019 – Feb 17, 2021 · Past); Accuray Incorporated (EVP Engineering & Global · Jan 1, 2013 – Oct 31, 2013 · Past) | Director · Since at least Oct 30, 2018 |
| Nicolas M. Barthelemy Other companies: Repligen Corporation (Director · Since at least May 11, 2016); 908 Devices Inc. (Director · Dec 17, 2020 – Jun 15, 2022 · Past); Standard BioTools Inc. (Director · Mar 23, 2017 – Apr 1, 2022 · Past) | Director · Oct 24, 2019 – Nov 21, 2022 · Past |
| Katryn Blake Other companies: TripAdvisor, Inc. (Director · Since at least Jun 8, 2021); Ally Financial Inc. (Director · Oct 9, 2020 – Jan 7, 2022 · Past) | Director · Since at least Aug 5, 2025 |
| Adam Laponis Other companies: Eargo, Inc. (Chief Financial Officer · Oct 15, 2020 – Nov 20, 2023 · Past) | Chief Financial Officer · Since at least Jan 8, 2024 |
| Emily Leproust Other companies: GeneDx Holdings Corp. (Director · Since at least Jun 18, 2026) | Chief Executive Officer, Director · Since at least Apr 21, 2026 |
| Fred B Craves Other companies: Madrigal Pharmaceuticals, Inc. (Director · Jun 11, 2018 – Mar 12, 2025 · Past) | Director · Oct 30, 2018 – Jul 23, 2019 · Past |
| Kevin Bruce Yankton Other companies: Varex Imaging Corporation (Chief Accounting Officer · Jan 27, 2017 – Feb 18, 2021 · Past) | Chief Accounting Officer · Aug 5, 2021 – May 17, 2023 · Past |
| Michael Sullivan Other companies: Illumina, Inc. (Chief Commercial Officer · Since at least Jul 9, 2026) | Corporate Communications Manager · Oct 6, 2025 – Nov 4, 2026 · Past |
All 28 people
| Person | Seat |
|---|---|
| Robert B. Chess Other companies: Nektar Therapeutics (Chairman of the Board, Nektar Therapeutics · Since at least Feb 24, 2006) | Director · Since at least Oct 30, 2018 |
| Angela Bitting | Senior Vice President, Corporate Affairs; Chief Corporate Responsibility Officer · Since at least May 4, 2026 |
| Bob Ragusa | Until Oct 7, 2026 · Past |
| Dennis Cho | Chief Legal Officer and Corporate Secretary · Since at least May 4, 2026 |
| Jimmy Jin | Senior Vice President of Product and Marketing · Since at least Nov 4, 2026 |
| Mark Buck | Senior Vice President of Operations · Since at least Nov 5, 2026 |
| Mark Daniels | See Remarks · Oct 24, 2020 – Apr 1, 2021 · Past |
| Martin Kunz | SVP, Operations · Feb 4, 2019 – Oct 24, 2019 · Past |
| Melissa Starovasnik | Director · Since at least Apr 1, 2026 |
| Mike Fero | Chief Information Officer · Since at least Nov 4, 2026 |
| Nicole Moreno | Senior Vice President of Sales and Support · Since at least Nov 5, 2026 |
| Patrick Finn | President and Chief Operating Officer · Since at least Sep 25, 2019 |
| Paula Green | SVP of Human Resources · Since at least May 4, 2026 |
| Robert F Werner | Chief Accounting Officer · Since at least Nov 2, 2023 |
| Siyuan Chen | Chief Technology Officer · Since at least Nov 5, 2026 |
| Trynka Shineman Blake | Aug 6, 2025 – Oct 7, 2026 · Past |
| William Banyai | See Remark · Oct 30, 2018 – May 3, 2024 · Past |
| Xiaoying Mai | Director · Oct 30, 2018 – Feb 6, 2024 · Past |
Log in to ask 6ix AI your own questions about Twist Bioscience Corporation.